Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells

作者: Francesca Grespi , Vivien Landré , Alina Molchadsky , Nicola Di Daniele , Luigi Tonino Marsella

DOI: 10.1038/CDDIS.2016.419

关键词:

摘要: The tumour suppressor p53 plays an important role in somatic cell reprogramming. While wild-type reduces reprogramming efficiency, mutant exerts a gain of function activity that leads to increased efficiency. Furthermore, induced pluripotent stem cells expressing lose their pluripotency vivo and form malignant tumours when injected mice. It is therefore great interest identify targets (wild type mutant) are responsible for this phenotype during reprogramming, as these could be exploited therapeutic use, is, formation with high but no oncogenic potential. Here we studied the transcriptional changes microRNA series mouse embryonic fibroblasts have undergone transition wild type, knock out or status order microRNAs whose expression dependent on p53. We identified number microRNAs, known functions differentiation carcinogenesis, which was cells. detected several uncharacterised were regulated differentially different backgrounds, suggesting novel pluripotency.

参考文章(89)
T L Slatter, N Hung, S Bowie, H Campbell, C Rubio, D Speidel, M Wilson, M Baird, J A Royds, A W Braithwaite, Δ122p53, a mouse model of Δ133p53α, enhances the tumor-suppressor activities of an attenuated p53 mutant. Cell Death and Disease. ,vol. 6, ,(2015) , 10.1038/CDDIS.2015.149
T Soussi, K G Wiman, TP53: an oncogene in disguise Cell Death & Differentiation. ,vol. 22, pp. 1239- 1249 ,(2015) , 10.1038/CDD.2015.53
A Di Ruscio, F Patti, R S Welner, D G Tenen, G Amabile, Multiple sclerosis: getting personal with induced pluripotent stem cells Cell Death and Disease. ,vol. 6, pp. 0- ,(2015) , 10.1038/CDDIS.2015.179
A Stedman, S Beck-Cormier, M Le Bouteiller, A Raveux, S Vandormael-Pournin, S Coqueran, V Lejour, L Jarzebowski, F Toledo, S Robine, M Cohen-Tannoudji, Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells Cell Death & Differentiation. ,vol. 22, pp. 1865- 1876 ,(2015) , 10.1038/CDD.2015.57
S Kumar, H Ingle, S Mishra, R S Mahla, A Kumar, T Kawai, S Akira, A Takaoka, A A Raut, H Kumar, IPS-1 differentially induces TRAIL , BCL2 , BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity Cell Death and Disease. ,vol. 6, ,(2015) , 10.1038/CDDIS.2015.122
Jiao Li, Jun Dong, Zhen‐hui Zhang, Dong‐Cheng Zhang, Xiang‐Yu You, Yun Zhong, Min‐Sheng Chen, Shi‐Ming Liu, miR‐10a restores human mesenchymal stem cell differentiation by repressing KLF4 Journal of Cellular Physiology. ,vol. 228, pp. 2324- 2336 ,(2013) , 10.1002/JCP.24402
S. Vimalraj, Nicola C. Partridge, N. Selvamurugan, A positive role of microRNA-15b on regulation of osteoblast differentiation. Journal of Cellular Physiology. ,vol. 229, pp. 1236- 1244 ,(2014) , 10.1002/JCP.24557
Qing Wei, Rong Lei, Guohong Hu, Roles of miR-182 in sensory organ development and cancer. Thoracic Cancer. ,vol. 6, pp. 2- 9 ,(2015) , 10.1111/1759-7714.12164
Xin Zhang, Ramona Schulz, Shelley Edmunds, Elke Krüger, Elke Markert, Jochen Gaedcke, Estelle Cormet-Boyaka, Michael Ghadimi, Tim Beissbarth, Arnold J. Levine, Ute M. Moll, Matthias Dobbelstein, MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP Molecular Cell. ,vol. 59, pp. 243- 257 ,(2015) , 10.1016/J.MOLCEL.2015.05.036
Francesca Lovat, Matteo Fassan, Pierluigi Gasparini, Lara Rizzotto, Luciano Cascione, Marco Pizzi, Caterina Vicentini, Veronica Balatti, Dario Palmieri, Stefan Costinean, Carlo M Croce, None, miR-15b/16-2 deletion promotes B-cell malignancies. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 11636- 11641 ,(2015) , 10.1073/PNAS.1514954112